Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HSK 31858

Next Previous
Drug Profile

HSK 31858

Alternative Names: CHF-10196; HSK-31858

Latest Information Update: 31 Jan 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Haisco Pharmaceutical Group
  • Class Amides; Antiasthmatics; Antibronchitics; Benzoxazoles; Fluorobenzenes; Ketones; Nitriles; Oxazepines; Small molecules
  • Mechanism of Action Dipeptidyl peptidase I inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Bronchiectasis
  • Phase II Asthma; Chronic obstructive pulmonary disease

Most Recent Events

  • 31 Jan 2026 Chemical structure information (IUPAC name, molecular formula) added.
  • 28 Nov 2025 No recent reports of development identified for phase-I development in Bronchiectasis(In volunteers) in Australia (PO, Tablet)
  • 11 Aug 2025 Haisco Pharmaceutical Group initiates enrolment in a phase I trial for Healthy volunteers in China (PO)(NCT07134465)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top